Affinity Group
Co-chaired by Dr. Pergam and Dr. Liu, the affinity group “Infectious Diseases in the Immunocompromised Host” is a speaking series on a topic of the speaker’s choice, related to immunocompromised hosts. The lectures are typically 30 minutes, followed by a 30 minute Q&A. This speaking series is an informal event, meant to foster novel collaborations, present new research ideas and to enhance understanding within our niche research community.
Infection Prevention and Antimicrobial Stewardship in Cancer Care Mini-Symposium
Fred Hutch & Austin Health Collaboratory | May 16, 2025 | Seattle, WA
On May 16, 2025, the Fred Hutchinson Cancer Center Infectious Disease Sciences Program and Austin Health Australia collaborated to present a mini-symposium highlighting novel developments in research and cancer care related to infection prevention and antimicrobial stewardship. The event, complementing the Affinity Group on Infectious Diseases in the Immunocompromised Host and the biennial 5th Symposium on Infectious Diseases in the Immunocompromised Host, brought together international experts in a more intimate setting to drive novel partnerships, disseminate groundbreaking research, and ultimately improve outcomes in cancer care.
The program opened with a welcome from Drs. Catherine Liu and Steve Pergam, followed by seven engaging presentations on topics such as antimicrobial allergies by Prof. Jason Trubiano, antimicrobial resistance management by Dr. Jason Kwong, prophylaxis strategies in transplantation by Dr. Brennan Collis, and emerging infections in patients receiving novel therapies by Dr. Gemma Reynolds. The afternoon session featured discussions on diagnostic stewardship by Dr. Emily Rosen, international clinical trial coordination by Dr. Julian Lindsay, and defining nosocomial invasive aspergillosis by Dr. Paulina Vega, with breakout meetings facilitating cooperative dialogue among participants. The event concluded with a campus tour and a social hour at the White Swan Public House, offering valuable networking opportunities.
The symposium showcased the power of international collaboration and laid the groundwork for future joint initiatives in infectious disease prevention and care for vulnerable patient populations.
June 4th Affinity Group - Career Pathways in Infectious Disease
Affinity Group speakers Dr. Ison and Dr. Chin-Hong with co-chairs Dr. Pergam and Dr. Liu
Affinity Group speakers Dr. Ison and Dr. Chin-Hong with the group.
Cross collaboration
Dr. Sanjeet Dadwal and Zahra Eftekhari (City of Hope) speak to fellows, clinical coordinators, and students regarding machine-learning based sepsis prediction in stem cell transplants.
Peter Chin-Hong in conversation.
Mentoring dinner with Dr. Eric Lofgren after his talk "Dirty Doctors and Pestilent Puppies: Modeling Infection Control at the Human Animal Interface"
Dr. Lofgren in conversation with fellows, clinical coordinators, and students
The Exception as the Rule -Antimicrobial Resistance and Stewardship in Patients with Leukemia
Sam Aitken, PharmD (MD Anderson) l August 16, 2019
Multidrug Resistant Bacteria: Common Cause of Neutropenic Fever and Mortality Among Patients with Hematologic Malignancies in Uganda
Maggie Lubwama (Uganda Cancer Institute) l June 13, 2019
Machine-Learning Based Sepsis Prediction in Stem Cell Transplant Recipients
Sanjeet Dadwal, MD (City of Hope) l June 7, 2019
Beta Lactam and Other Antibiotic Allergies in Patients Undergoing Solid Organ and Hematopoietic Cell Transplantation
Hannah Imlay, MD (University of Washington) l May 15, 2019
Identifying Sepsis in Hematopoietic Cell Transplant Recipients with Diagnostic Criteria, a Look at Current Standards and Future Opportunities
Maggie Lind, PhD Candidate (University of Washington) l April 25, 2019
Impact of fluoroquinolone neutropenic prophylaxis on the antimicrobial susceptibility and epidemiology of invasive Pseudomonas aeruginosa infections
Morgan Hakki, MD (Oregon Health and Science University) l March 11, 2019
Mutual interaction between respiratory virus infections and antibiotics
Chikara Ogimi, MD (Seattle Children's) l November 8, 2018
Demystifying the Antibiotic Allergy Evaluation
Lahari Rampur, MD (University of Washington) l October 29, 2018
Viral GI Pathogens in Transplantation
Dr. Michael Ison (Northwestern) l September 20, 2018
Dirty Doctors and Pestilent Puppies: Modeling Infection Control at the Human Animal Interface
Dr. Eric Lofgren (Washington State University) l July 5, 2018
Career Pathways in Infectious Disease
Dr. Michael Ison (Northwestern) and Dr. Peter Chin-Hong (UCSF) l June 4, 2018
Integrative Diagnosis of Invasive Fungal Sinusitis: Opportunities for Quality Improvement
Dr. Andrew Bryan (University of Washington) l April 23, 2018
Do Individualized Antibiotic Plans (IAPs) impact outcomes for BMT patients?
Dr. Scott Weissman (Seattle Children's) | Jan. 23, 2018
New Frontiers in Antibiotic Stewardship
Dr. Erica Stohs, Pergam Group | Dec. 14, 2017
Mucormycosis and Hospital Linens: Insights from an Investigation
Dr. Hong Nguyen (University of Pittsburg) | Nov. 6, 2017
Influenza Vaccines in the Immunocomromised Host
Dr. Natasha Halasa, Vanderbilt l August 25, 2017
Improving Outpatient Care and Reducing Healthcare Resource Utilization in AML
Dr. Anna Halpern | Aug. 7, 2017
The Challenge of Preventing Infectious Disease in HSCT Patients in a Tropical Country
Dr. Silvia Costa, Hospital das Clinicas, University of Sao Paulo, Brazil | June 21, 2017
© 2025 Fred Hutchinson Cancer Center, a 501(c)(3) nonprofit organization.